Graduate School of Medical Sciences News

Weill Cornell Medicine has experienced dynamic growth in its research enterprise over the past five years, an achievement that underscores the institution’s mission to provide patients with the most advanced treatments and therapies.

The powerful but temporary benefits of ketamine against depression might be extended if the new brain-cell connections it promotes could be preserved, according to a new study.

Long-term spaceflight causes more changes to gene expression than shorter trips, especially to the immune system and DNA repair systems, according to research by Weill Cornell Medicine and NASA investigators as part of NASA’s Twins Study, which followed the only set of identical twin astronauts for more than two years.  

Dr. Ting Jia, PhD ’09, taps his science skills to guide investment in biotech

A drug already approved for anemia offers hope for people leukemia.

On Feb. 25, 42 students in the Class of 2021 earned their short white coats during the annual white coat ceremony, launching the next phase of their medical careers.

Dr. Carl Nathan, chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine, has been awarded the institution’s Joan and Sanford I. Weill Exemplary Achievement Award.

Most of the reasons why American patients receive care from multiple providers are related to numerous modifiable causes such as patient preferences, physician referrals and health system factors —not medical need—according to a qualitative study by Weill Cornell Medicine researchers.  

The third annual NYC Health Hackathon brought together nearly 200 students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus, and several local and national academic institutions, to develop high-tech healthcare innovations. 

Chelsea Clinton is a public health advocate, researcher and educator. But being a mother has deepened her passion for children’s health, she explained in a talk on Feb. 5 at Weill Cornell Medicine.

New studies from Weill Cornell Medicine researchers have revealed the importance of two gene-regulation proteins in the development of common immune cell cancers called lymphomas.

Dr. Barbara Hempstead, a preeminent physician-scientist, educator and academic leader, has been appointed dean of the Weill Cornell Graduate School of Medical Sciences, effective Jan. 14.

An innovation in gene-splicing technology lands MD-PhD student Dr. Alex Pérez, PhD ’17, on Forbes’s ‘30 Under 30’ list.

Seven Weill Cornell Medicine faculty members leading multi-institutional research teams were awarded grants from The Starr Foundation's 12th Starr Cancer Consortium Grant Competition to fund their innovative cancer research projects.

Weill Cornell Medicine’s summer programs for minority undergrads have inspired generations of students to pursue careers as physicians and scientists

A protein induced by gut microbes is vital in healing colons that have become inflamed due to a short-term form of colitis, Weill Cornell Medicine researchers discovered in a new study. 

A study of the dual pathways that process the essential vitamin folate by Weill Cornell Medicine investigators unexpectedly revealed a new way the cancer drug methotrexate works and may suggest strategies to boost its cancer-killing effects.

Common drug treatments that lead to changes in gut fungi can persistently exacerbate allergic airway diseases such as asthma.

Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant (P01) from the National Cancer Institute (NCI) to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time. 

Measuring brain activity in response to hearing a brief narrative can identify patients with severe brain injury who have preserved high-level cognition despite showing limited or no consciousness at the bedside, according to a study by Weill Cornell Medicine researchers.